Hyzaar is a fixed-dose combination of the antihypertensive agent losartan and the diuretic hydrochlorothiazide. It is prescribed to treat high blood pressure in adults who require dual therapy. The medication works by reducing vascular resistance through angiotensin ii receptor blockade. Losartan blocks at1 receptors, preventing angiotensin ii mediated vasoconstriction and aldosterone release. Hydrochlorothiazide promotes sodium and water excretion by the kidneys, decreasing plasma volume and cardiac output. Together, these actions lead to a lower systemic blood pressure and improved cardiac workload. The active ingredients act on the renin-angiotensin system and tubular reabsorption to achieve a synergistic antihypertensive effect. This coordinated mechanism results in sustained control of arterial pressure without significant changes in heart rate.

Hyzaar is a combination drug that contains hydrochlorothiazide and losartan potassium. It is prescribed to treat high blood pressure by relaxing blood vessels and reducing fluid volume. Hydrochlorothiazide works by acting on the kidneys to increase salt and water excretion, lowering blood pressure. Losartan blocks the action of a hormone that causes blood vessels to tighten, further promoting vessel relaxation. Together they provide additive effects that achieve better blood pressure control than either component alone. The medication thus helps the heart pump more efficiently and reduces strain on the cardiovascular system. Its therapeutic role is to maintain cardiovascular health by keeping blood pressure within a healthy range. The combined pharmacological actions target both fluid balance and vascular tone for optimal hypertension management.

Hyzaar may cause dizziness or lightheadedness especially when standing up quickly. It can sometimes lead to a dry cough or sore throat. Fatigue or unusual weakness is also reported by some patients. Changes in potassium levels may occur and can affect heart rhythm in rare cases. Headache and blurred vision are less common but have been noted. Swelling of the ankles or feet may develop due to fluid retention. Some people experience increased urination or changes in taste sensation.

Hyzaar can cause dizziness as a common side effect. Headache frequently occurs in patients taking the medication. Fatigue is often reported during treatment. A dry cough may develop in some individuals. Low potassium levels are a possible electrolyte disturbance. Skin rash can appear in a minority of cases.